North Carolina Biotechnology Center :: BT Catalyst

WEEKLY E-NEWS FROM THE NORTH CAROLINA BIOTECHNOLOGY CENTER

February 5, 2009
 

biotech 2009Where can you see a governor, a Nobel prize winner, industry and academic leaders, and many more on a single stage? At the Raleigh Convention Center on Feb. 16 and 17. Join us for Biotech 2009. Listen to the Podcast announcement.


IN FOCUS FEATURE

Biotechnology Program Connects Post-Docs with Companies

FROM OUR WEB SITE


 

 

In Focus

Biotechnology Program Connects Post-Docs with Companies

North Carolina biotechnology companies have until March 1 to apply to become sponsor companies in this year's Industrial Fellowship program. The program places recent Ph.D. graduates into North Carolina biotechnology companies for a two-year fellowship to gain industry-oriented research experience - and thus improve their competitiveness for high-level industry scientific positions.

Read more about the program and how to apply in this week's In Focus.

 

Leader Interviews
Meet Christy Shaffer. She's the president and CEO of Inspire Pharmaceuticals in Durham — and has served as a member of the North Carolina Biotechnology Center board of directors. She is featured this week on I Am Biotech, where in a three-part interview, she discusses how she got involved in biotech and why she is so passionate about her work on treatments for Cystic Fibrosis.

 

From Our Web Site

BioDelivery: Drug Looks Good
BioDelivery Sciences of Raleigh has reported encouraging Phase I clinical trial results for Bioral Amphotericin B, its lead product candidate incorporating its Bioral drug delivery technology.

Inspire Testing its Dry Eye Treatment
Durham's Inspire Pharmaceuticals got the go-ahead from the FDA to try another Phase III clinical trial for its experimental dry-eye treatment, Prolacria.

BioMarck Gets $990K from NIH
Raleigh's BioMarck Pharmaceuticals has received $990,000 of a $3 million, three-year grant from the National Institutes of Health to help it develop its experimental inhaled treatment for lung disease.

Exigent Pharmaceuticals Develops Anti-Bacterial Treatment
The University of North Carolina at Chapel Hill spin-out company is developing a new type of anti-bacterial treatment that could help stem the tide of deaths and complications from hospital-acquired, drug-resistant infections.

Targacept to Present at BIO CEO & Investor Conference
Targacept announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 11th Annual BIO CEO and Investor Conference.

ConvaTec to Add 30 Jobs in Greensboro
Medical device maker ConvaTec has settled on Greensboro to expand its manufacturing operations.

New Preclinical Surgical Services Announced at PTRP
Vince Mendenhall, D.V.M., Ph.D., joins Wake Forest University Baptist Medical Center as director of the new preclinical surgical services section.

Trials Show Mardil Heart Device Helped
Morrisville-based Mardil reported that its first human test, in India, shows promise for its experimental heart device in treating valve problems.

 

News from Other Sites

BioMarck Receives $990,000 NIH Grant
The Raleigh company working on new medicines for pulmonary diseases, will fund clinical tests of its experimental treatment for chronic obstructive pulmonary disease (COPD).
From Local Tech Wire
From the Raleigh News & Observer

Biotech Conference will Feature NCRC
The biotech hub in Kannapolis scored a one-hour panel discussion at Biotech 2009, the 18th annual conference hosted by the Council for Entrepreneurial Development in Raleigh.
From the Salisbury Post

N.C. Research Campus Ready for Jobs to Come
The Research Campus, with its three massive but mostly empty buildings outfitted with some of the world's best scientific equipment, could launch projects that would put people to work immediately.
From the Salisbury Post


 

Community Watch

  • Wilmington-based Gene Express has signed a non-exclusive distribution agreement with Biogenuix Medsystems giving the New Delhi marketing, distributing and contract research firm rights to distribute Gene Express's Standardized RT-PCR reagents and research molecular diagnostic products in India. More
  • Jorge Leon, Ph.D., one of the founders of the molecular diagnostics and applied genomics business at Quest Diagnostics, has joined the scientific advisory board of ParagonDx, a Morrisville genetic and molecular testing diagnostics company. Leon, of St. Paul, Minn., started a consulting business in 2002. More
  • bioMerieux, a French medical diagnostics company with U.S. headquarters in Durham, has signed an exclusive referral agreement with Nashville, Tennessee-based ICNet Systems, a purveyor of software targeting infection control in hospitals and other health care settings. ICNet Systems is an affiliate of ICNet Ltd., based in Gloucestershire, England. More
 

Events Calendar

February 13
Life & Physical Sciences Research Symposium
(Greensboro)

February 16-17, 2009
Biotech 2009
(Raleigh)

February 19
Science & Society Series
(Greensboro)

February 19
BioNight
(Charlotte)


Save the Date

May 13-14, 2009
Chapel Hill Drug Conference
(Chapel Hill)

May 18-21, 2009
BIO International Convention
NC Pavilion Sponsorship
(Atlanta)

July 19-22, 2009
World Congress on Industrial Biotechnology
(Montreal)

View our complete listing of events across North Carolina.


This newsletter was sent Thursday, February 5, 2009. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.

Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.